493 related articles for article (PubMed ID: 17189219)
1. Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation.
Madoiwa S; Nunomiya S; Ono T; Shintani Y; Ohmori T; Mimuro J; Sakata Y
Int J Hematol; 2006 Dec; 84(5):398-405. PubMed ID: 17189219
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T
Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
[TBL] [Abstract][Full Text] [Related]
3. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
[TBL] [Abstract][Full Text] [Related]
4. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients.
Voves C; Wuillemin WA; Zeerleder S
Blood Coagul Fibrinolysis; 2006 Sep; 17(6):445-51. PubMed ID: 16905947
[TBL] [Abstract][Full Text] [Related]
5. A prospective analysis of disseminated intravascular coagulation in patients with infections.
Seki Y; Wada H; Kawasugi K; Okamoto K; Uchiyama T; Kushimoto S; Hatada T; Matsumoto T; Imai H;
Intern Med; 2013; 52(17):1893-8. PubMed ID: 23994978
[TBL] [Abstract][Full Text] [Related]
6. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
7. High macrophage migration inhibitory factor levels in disseminated intravascular coagulation patients with systemic inflammation.
Gando S; Sawamura A; Hayakawa M; Hoshino H; Kubota N; Nishihira J
Inflammation; 2007 Aug; 30(3-4):118-24. PubMed ID: 17534704
[TBL] [Abstract][Full Text] [Related]
8. The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation.
Gando S; Hayakawa M; Sawamura A; Hoshino H; Oshiro A; Kubota N; Jesmin S
Thromb Res; 2007; 121(1):67-73. PubMed ID: 17397908
[TBL] [Abstract][Full Text] [Related]
9. Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome.
Gando S; Nakanishi Y; Tedo I
Crit Care Med; 1995 Nov; 23(11):1835-42. PubMed ID: 7587259
[TBL] [Abstract][Full Text] [Related]
10. A low TAFI activity and insufficient activation of fibrinolysis by both plasmin and neutrophil elastase promote organ dysfunction in disseminated intravascular coagulation associated with sepsis.
Hayakawa M; Sawamura A; Gando S; Jesmin S; Naito S; Ieko M
Thromb Res; 2012 Dec; 130(6):906-13. PubMed ID: 22353215
[TBL] [Abstract][Full Text] [Related]
11. Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit.
Okabayashi K; Wada H; Ohta S; Shiku H; Nobori T; Maruyama K
Am J Hematol; 2004 Jul; 76(3):225-9. PubMed ID: 15224356
[TBL] [Abstract][Full Text] [Related]
12. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.
Asakura H; Ontachi Y; Mizutani T; Kato M; Saito M; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Nakao S
Crit Care Med; 2001 Jun; 29(6):1164-8. PubMed ID: 11395595
[TBL] [Abstract][Full Text] [Related]
13. Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis.
Ikeda M; Matsumoto H; Ogura H; Hirose T; Shimizu K; Yamamoto K; Maruyama I; Shimazu T
J Crit Care; 2018 Feb; 43():48-53. PubMed ID: 28843664
[TBL] [Abstract][Full Text] [Related]
14. Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis.
Lin SM; Wang YM; Lin HC; Lee KY; Huang CD; Liu CY; Wang CH; Kuo HP
Crit Care Med; 2008 Mar; 36(3):683-9. PubMed ID: 18431261
[TBL] [Abstract][Full Text] [Related]
15. The association between plasminogen activator inhibitor type-1 and clinical outcome in paediatric sepsis.
Pudjiadi AH; Adhyanisitha K; Pusponegoro HD; Suyoko DEM; Satari HI; Kaswandani N
Blood Coagul Fibrinolysis; 2020 Sep; 31(6):377-381. PubMed ID: 32815912
[TBL] [Abstract][Full Text] [Related]
16. Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation.
Fukao H; Ueshima S; Okada K; Yamamoto K; Matsuo T; Matsuo O
Thromb Res; 1992 Oct; 68(1):57-65. PubMed ID: 1280377
[TBL] [Abstract][Full Text] [Related]
17. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation.
Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi K; Shirakawa S; Hayashi T
Am J Hematol; 1993 Oct; 44(2):85-8. PubMed ID: 8266924
[TBL] [Abstract][Full Text] [Related]
18. Changes in plasma levels of natural anticoagulants in disseminated intravascular coagulation: high prognostic value of antithrombin and protein C in patients with underlying sepsis or severe infection.
Choi Q; Hong KH; Kim JE; Kim HK
Ann Lab Med; 2014 Mar; 34(2):85-91. PubMed ID: 24624342
[TBL] [Abstract][Full Text] [Related]
19. Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma.
Kushimoto S; Gando S; Saitoh D; Ogura H; Mayumi T; Koseki K; Ikeda T; Ishikura H; Iba T; Ueyama M; Eguchi Y; Otomo Y; Okamoto K; Endo S; Shimazaki S;
Thromb Haemost; 2008 Dec; 100(6):1099-105. PubMed ID: 19132236
[TBL] [Abstract][Full Text] [Related]
20. Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study.
Koyama K; Madoiwa S; Nunomiya S; Koinuma T; Wada M; Sakata A; Ohmori T; Mimuro J; Sakata Y
Crit Care; 2014 Jan; 18(1):R13. PubMed ID: 24410881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]